Presentations

Recent activity on improving prior authorization

Recent activity on improving prior authorization

At the NAIC Summer Meeting, consumer representatives, including Carl Schmid, provide an update on recent state legislation to regulate insurers’ use of the prior authorization process for patients. This includes a NY state law prohibiting Prior Authorization for all PrEP drugs and a pending bill in CA that addresses the use of AI in the prior authorization process.

read more
The Role & Impact of  the CDC & its Grantees in  Ending HIV in the U.S.

The Role & Impact of the CDC & its Grantees in Ending HIV in the U.S.

Please RSVP to attend The Role & Impact of the CDC & its Grantees in Ending HIV in the U.S. on Tuesday, June 4th from 3:00-4:30 pm in Rayburn 2060 sponsored by HIV+Hepatitis Policy Institute and NASTAD and in cooperation with the Office of Congresswoman Barbara Lee, co-chair of the HIV/AIDS Caucus.

read more
Biomedical HIV Prevention Summit: Scaling Up PrEP Now by Leveraging Existing Programs

Biomedical HIV Prevention Summit: Scaling Up PrEP Now by Leveraging Existing Programs

HIV+Hepatitis Policy Institute will convene a panel on Friday, April 19, 2024, at the Biomedical HIV Prevention Summit to examine how PrEP is provided today by entities including community health centers, CBOs, pharmacies, telemedicine platforms, and state health departments. We will examine how this work is financed by leveraging existing programs and systems, as well as current barriers and what can be done to close PrEP access gaps in underserved populations.

read more
What the new section 1557 rule means for health insurance non-discrimination protections and considerations for regulators

What the new section 1557 rule means for health insurance non-discrimination protections and considerations for regulators

Carl Schmid joined National Health Law Program’s Wayne Turner, Whitman Walker Institute’s Kellan Baker, and National Women’s Law Center’s Dorianne Mason to discuss what the new section 1157 rule means for health insurance non-discrimination protections at the NAIC Spring Meeting. Carl focused on provisions of the proposed rule that pertain to prescription drugs.

read more

Pin It on Pinterest